LOCALLY ADVANCED NSCLC
79MO PACIFIC-R: Real-world characteristics of unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy

https://doi.org/10.1016/S1556-0864(21)01921-3Get rights and content
Under an Elsevier user license
open archive

Cited by (0)